Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.436 EUR | +1.66% | -7.63% | -27.20% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.20% | 502M | |
+25.66% | 48.09B | |
+48.09% | 40.62B | |
-1.72% | 40.43B | |
-6.20% | 28.36B | |
+7.93% | 24.89B | |
-19.72% | 19.01B | |
+29.28% | 12.09B | |
+0.21% | 11.88B | |
+0.76% | 11.8B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Signs Revised COVID-19 Vaccine Supply Deal With EU